Feasibility and usefulness of recommended screenings at long-term follow-up clinics for hematopoietic cell transplant survivors

被引：0
作者：
Saiko Kurosawa
Takuhiro Yamaguchi
Ayako Mori
Mayumi Tsukagoshi
Ikue Okuda
Masako Ikeda
Takao Ueno
Yutaka Saito
Yukiko Aihara
Yuko Matsuba
Shigeo Fuji
Takuya Yamashita
Chitose Ogawa
Ayumu Ito
Takashi Tanaka
Yoshihiro Inamoto
Sung-Won Kim
Takahiro Fukuda
机构：
[1] National Cancer Center Hospital,Department of Hematopoietic Stem Cell Transplantation
[2] Ina Central Hospital,Department of Oncology
[3] Tohoku University Graduate School of Medicine,Division of Biostatistics
[4] National Cancer Center Hospital,Nursing Division
[5] International University of Health and Welfare Hospital,Nursing Division
[6] National Cancer Center Hospital,Department of Dentistry
[7] National Cancer Center Hospital,Endoscopy Division
[8] National Cancer Center Hospital,Department of Ophthalmic Oncology
[9] Kachidoki Women’s Clinic,Department of Hematology
[10] Osaka International Cancer Institute,Department of Hematology
[11] St. Luke’s International Hospital,Department of Pediatric Oncology
[12] National Cancer Center Hospital,undefined
来源：
Supportive Care in Cancer | 2022年 / 30卷
关键词：
Long-term follow-up; Late effects; Screening and prevention; Hematological disease; Allogeneic hematopoietic cell transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2767 / 2776
页数：9
相关论文
共 97 条
[1]  
Gyurkocza B(2010)Allogeneic hematopoietic cell transplantation: the state of the art Expert Rev Hematol 3 285-299
[2]  
Rezvani A(2010)Reduced mortality after allogeneic hematopoietic-cell transplantation N Engl J Med 363 2091-2101
[3]  
Storb RF(2011)Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? J Clin Oncol 29 805-813
[4]  
Gooley TA(2016)Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant 51 553-559
[5]  
Chien JW(2013)Prevalence of hematopoietic cell transplant survivors in the United States Biol Blood Marrow Transplant 19 1498-1501
[6]  
Pergam SA(2010)Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation J Clin Oncol 28 1011-1016
[7]  
Hingorani S(2010)Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study Blood. 116 3129-39; quiz 377
[8]  
Sorror ML(2014)Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease Ann Oncol 25 435-441
[9]  
Boeckh M(2009)Solid cancers after allogeneic hematopoietic cell transplantation Blood 113 1175-1183
[10]  
Horan JT(2017)Increased incidence of oral and gastrointestinal secondary cancer after allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant 52 789-791
12345678910